Isolation, Synthesis and Structures of Cytotoxic Ginsenoside Derivatives
Open Access
- 5 September 2007
- Vol. 12 (9), 2140-2150
- https://doi.org/10.3390/12092140
Abstract
Four known ginsenosides: ginsenoside-Rb1 (1), Rb3 (2), Rd (3) and Re (4) were isolated from the methanolic extract of the traditional Chinese medicine Panax ginseng C. A. Meyer. Further enzyme reactions and chemical modifications led us to obtain ginsenoside-M1 (5) and synthesize three novel mono-esters of ginsenoside-M1, ginsenoside-DM1 (6), PM1 (7) and SM1 (8) 30 - 50% of yield via a facile and green synthetic strategy. The structures were elucidated on the basis of extensive 1D- and 2DNMR, as well as high resolution ESI-TOF mass spectroscopic analyses. The isolated and synthetic compounds were tested in an anti-tumor bioassay, and compounds 5-8 showed considerable cytotoxicity (SRB) against several human cancer cell lines (breast cancer MCF-7, skin melanoma SK-MEL-2 and human ovarian carcinoma B16), but moderate effects on lung carcinoma COR-L23. The other ginsenosides showed no effects.This publication has 19 references indexed in Scilit:
- Ginsenoside Rh2 is One of the Active Principles of Panax Ginseng Root to Improve Insulin Sensitivity in Fructose-rich Chow-fed RatsHormone and Metabolic Research, 2007
- Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic ratsEuropean Journal of Pharmacology, 2006
- Isolation and determination of ginsenosides in American ginseng leaves and root extracts by LC-MSAnalytical and Bioanalytical Chemistry, 2005
- Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cellsCancer Chemotherapy and Pharmacology, 2005
- Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skinCarcinogenesis: Integrative Cancer Research, 2004
- DEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATIONDrug Metabolism and Disposition, 2003
- Pharmacokinetics of Ginsenoside Deglycosylated by Intestinal Bacteria and Its Transformation to Biologically Active Fatty Acid Esters.Biological & Pharmaceutical Bulletin, 2000
- Drug Metabolism: Intestinal Bacterial Hydrolysis is Required for the Appearance of Compound K in Rat Plasma after Oral Administration of Ginsenoside Rb1 from Panax ginsengJournal of Pharmacy and Pharmacology, 1998
- Ginseng intestinal bacterial metabolite IH901 as a new anti-metastatic agentArchives of Pharmacal Research, 1997
- Effects of bilayer cholesterol on human erythrocyte hexose transport protein activity in synthetic lecithin bilayersBiochemistry, 1985